Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management 2023-01-17 22:00
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management 2023-01-17 20:41
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC 2023-01-17 19:42
Ascletis Announces Entering into a Supply Agreement of Ritonavir Tablets with Simcere 2023-01-17 08:29
AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China 2023-01-17 08:00
FDA Accepts GMP Plasmid DMF of OBiO Technology 2023-01-17 08:00
FAPON presents at 41st Annual J.P. Morgan Healthcare Conference 2023-01-16 22:09
Fiberstar, Inc. Launches New Organic Citrus Fibers for Food & Beverages 2023-01-16 22:05
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China 2023-01-16 18:00
MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe 2023-01-16 12:00
SD Biosensor Successfully Finishes JP Morgan Healthcare Conference 2023-01-13 15:11
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 17:00
JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA 2023-01-12 13:02
iNtRON is finalizing the SAL200 Tech Transfer 2023-01-12 09:34
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 06:00
Bio4t2 announces first patient infused with CAR-T targeting solid tumors 2023-01-11 09:00
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval 2023-01-11 09:00
Samsung Biologics receives the Terra Carta Seal in recognition of the company's commitment to creating a sustainable future 2023-01-11 08:01
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-2) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes 2023-01-11 00:00
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer 2023-01-10 21:05
1 93.5 94.5 95.5 96.5 97.5 415